Bone mineral density and bone turnover markers in patients receiving a single course of isotretinoin for nodulocystic acne

---

Copy For Citation

Tekin N. S., ÖZDOLAP S., SARIKAYA S., Keskin S.

INTERNATIONAL JOURNAL OF DERMATOLOGY, vol.47, no.6, pp.622-625, 2008 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 47 Issue: 6
• Publication Date: 2008
• Doi Number: 10.1111/j.1365-4632.2008.03534.x
• Journal Name: INTERNATIONAL JOURNAL OF DERMATOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.622-625
• Çanakkale Onsekiz Mart University Affiliated: No

Abstract

Background High-dose isotretinoin has been reported to have adverse effects on bone mineral density (BMD); however, studies evaluating changes in BMD with isotretinoin therapy at different dosages and with varying treatment durations have produced conflicting results.